BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER, FORMULATED USING CO-SUSPENSION DELIVERY TECHNOLOGY, IMPROVES LUNG FUNCTION AND EXACERBATION OUTCOMES IN PATIENTS WITH COPD WITHOUT A RECENT HISTORY OF EXACERBATIONS: SUBGROUP ANALYSIS OF KRONOS STUDY

被引：0
|
作者：
Martinez, Fernando [1 ]
Ferguson, Gary [1 ]
Bourne, Eric [1 ]
Ballal, Shaila [1 ]
Darken, Patrick [1 ]
Deangelis, Kiernan [1 ]
Aurivillius, Magnus [1 ]
Dorinsky, Paul [1 ]
Reisner, Colin [1 ]
机构：
[1] Univ Hosp, New York, NY USA
来源：
CHEST | 2019年 / 156卷 / 04期
关键词：
D O I：
10.1016/j.chest.2019.08.309
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2276A / 2277A
页数：2
相关论文
共 50 条
  • [31] Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma
    Miller, S. David
    Nyberg, Jack
    Siddiqui, Shahid
    Dorinsky, Paul
    St Rose, Earl
    Reisner, Colin
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (05) : 350 - 358
  • [32] Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease
    Gon, Yasuhiro
    Nishi, Koichi
    Sato, Kazuhiro
    Maes, Andrea
    Siddiqui, Shahid
    Hayashi, Nobuya
    Hirata, Hajime
    Martin, Ubaldo J.
    Reisner, Colin
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 135 - 144
  • [33] Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
    Hanania, Nicola A.
    Tashkin, Donald P.
    Kerwin, Edward M.
    Donohue, James F.
    Denenberg, Michael
    O'Donnell, Denis E.
    Quinn, Dean
    Siddiqui, Shahid
    Orevillo, Chad
    Maes, Andrea
    Reisner, Colin
    RESPIRATORY MEDICINE, 2017, 126 : 105 - 115
  • [34] Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial
    Rabe, K. F.
    Martinez, F. J.
    Singh, D.
    McLaren, J.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [35] Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
    Muro, Shigeo
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    Seki, Munehiro
    Duncan, Elizabeth A.
    Bowen, Karin
    Marshall, Jonathan
    Megally, Ayman
    Patel, Mehul
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [36] A phase III study of triple therapy with budesonide/glycopyrrolate/ formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
    Rabe, Klaus F.
    Martinez, Fernando J.
    Ferguson, Gary T.
    Wang, Chen
    Singh, Dave
    Wedzicha, Jadwiga A.
    Trivedi, Roopa
    St Rose, Earl
    Ballal, Shaila
    McLaren, Julie
    Darken, Patrick
    Reisner, Colin
    Dorinsky, Paul
    RESPIRATORY MEDICINE, 2019, 158 : 59 - 66
  • [37] Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
    Fabbri, Leonardo M.
    Kerwin, Edward M.
    Spangenthal, Selwyn
    Ferguson, Gary T.
    Rodriguez-Roisin, Roberto
    Pearle, James
    Sethi, Sanjay
    Orevillo, Chad
    Darken, Patrick
    St. Rose, Earl
    Fischer, Tracy
    Golden, Michael
    Dwivedi, Sarvajna
    Reisner, Colin
    RESPIRATORY RESEARCH, 2016, 17
  • [38] Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD
    Leonardo M. Fabbri
    Edward M. Kerwin
    Selwyn Spangenthal
    Gary T. Ferguson
    Roberto Rodriguez-Roisin
    James Pearle
    Sanjay Sethi
    Chad Orevillo
    Patrick Darken
    Earl St. Rose
    Tracy Fischer
    Michael Golden
    Sarvajna Dwivedi
    Colin Reisner
    Respiratory Research, 17
  • [39] Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD
    Gon, Yasuhiro
    Nishi, Koichi
    Sato, Kazuhiro
    Maes, Andrea
    Siddiqui, Shahid
    Hayashi, Nobuya
    Hirata, Hajime
    Reisner, Colin
    Martin, Ubaldo J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [40] Pharmacokinetics and safety of a single dose of the novel LAMA/LABA fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler, formulated using co-suspension delivery technology, in Japanese healthy subjects
    Reisner, Colin
    Miller, Joel
    DePetrillo, Paolo
    Maes, Andrea
    Siddiqui, Shahid
    Martin, Ubaldo J.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2018, 53 : 33 - 38
12345